Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 1/20 | 0.52 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.51 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.51 |
| ▸ | REN | P00797 | 1/20 | 0.51 |
| ▸ | NPY2R | P49146 | 7/20 | 0.50 |
| ▸ | NPY4R | P50391 | 7/20 | 0.50 |
| ▸ | NPY5R | Q15761 | 7/20 | 0.50 |
| ▸ | NPY1R | P25929 | 5/20 | 0.50 |
| ▸ | CALCRL | Q16602 | 2/20 | 0.50 |
| ▸ | CALCR | P30988 | 2/20 | 0.50 |
| ▸ | RAMP3 | O60896 | 1/20 | 0.50 |
| ▸ | FCGRT | P55899 | 2/20 | 0.50 |
| ▸ | EP300 | Q09472 | 1/20 | 0.49 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.49 |
| ▸ | NMUR2 | Q9GZQ4 | 1/20 | 0.49 |
| ▸ | NMUR1 | Q9HB89 | 1/20 | 0.49 |
| ▸ | NTSR2 | O95665 | 1/20 | 0.49 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31721895 | 0.96 | CALCRL (0.53) | OPRM1OPRD1CALCRLCALCRRAMP3 | |
| SCHEMBL30692047 | 0.92 | NPY2R (0.58) | NPY2RNPY4RNPY5RNPY1RCALCR | |
| SCHEMBL29845518 | 0.86 | REN (0.59) | SLC6A2RENNTSR2NTSR1 | |
| SCHEMBL30607299 | 0.85 | CALCR (0.57) | OPRM1OPRD1NPY2RNPY4RNPY5R | |
| SCHEMBL29404875 | 0.85 | OPRM1 (0.63) | SLC6A2OPRM1OPRD1NPY1RNMUR2 | |
| SCHEMBL30428845 | 0.85 | OPRM1 (0.63) | OPRM1OPRD1CALCRRAMP3NMUR2 | |
| SCHEMBL675630 | 0.84 | CAPN1 (0.48) | CALCRLCALCRRAMP3FCGRT | |
| SCHEMBL31182741 | 0.83 | CALCR (0.62) | NPY2RNPY4RNPY5RNPY1RCALCR | |
| SCHEMBL31130613 | 0.83 | CALCR (0.56) | OPRM1OPRD1CALCRRAMP3NMUR2 | |
| SCHEMBL29856042 | 0.83 | RAMP3 (0.56) | SLC6A2OPRM1OPRD1NPY2RNPY4R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4735021-A1 | COMBINATION THERAPY | Zealand Pharma A/S (DK) | 2026-05-06 | — | — | EP | disclosed |
| EP-4731239-A1 | ANALOGUES WITH IMPROVED PROPERTIES | Zealand Pharma A/S (DK) | 2026-04-29 | — | — | EP | disclosed |
| WO-2025003471-A1 | COMBINATION THERAPY | ZEALAND PHARMA A/S (DK) | 2025-01-02 | — | — | WO | disclosed |
| WO-2024261076-A1 | WEIGHT LOSS | ZEALAND PHARMA A/S (DK) | 2024-12-26 | — | — | WO | disclosed |
| WO-2024261259-A1 | ANALOGUES WITH IMPROVED PROPERTIES | ZEALAND PHARMA A/S (DK) | 2024-12-26 | — | — | WO | disclosed |
| US-12083164-B2 | Amylin analogues | ZEALAND PHARMA A/S (DK) | 2024-09-10 | — | — | US | disclosed |
| EP-4319798-A1 | LIQUID FORMULATIONS OF AMYLIN ANALOGUES | Zealand Pharma A/S (DK) | 2024-02-14 | — | — | EP | disclosed |
| WO-2023232781-A1 | LIQUID FORMULATIONS OF AMYLIN ANALOGUES | ZEALAND PHARMA A/S (DK) | 2023-12-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12083164-B2 | Amylin analogues | IAPP, GLP1R, AMY2A | SLC6A2 828/4885OPRM1 2772/4885OPRD1 2996/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.